Insider Trading & Ownership - Stelzer Laurie

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Stelzer Laurie
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-06-02
Sale
2023-06-02
7:15 pm
Mirati Therapeutics Inc.MRTXStelzer Laurie
Chief Financial Officer
4,647$37.06$172,21880,015
(Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-11-22
Option Award
2023-11-27
4:33 pm
N/A
2033-11-22
Spyre Therapeutics Inc.AGLEStelzer Laurie
Director
50,000$050,000
(Direct)
View
2023-08-09
Option Award
2023-08-10
4:26 pm
N/A
N/A
Mirati Therapeutics Inc.MRTXStelzer Laurie
Chief Financial Officer
22,297$37102,312
(Direct)
View
2023-06-08
Option Award
2023-06-12
5:55 pm
N/A
2033-06-07
PMV Pharmaceuticals Inc.PMVPStelzer Laurie
Director
21,500$021,500
(Direct)
View
2023-01-20
Option Award
2023-01-24
4:00 pm
N/A
2033-01-20
Mirati Therapeutics Inc.MRTXStelzer Laurie
CFO
72,320$0130,118
(Direct)
View
2022-06-08
Option Award
2022-06-10
8:00 pm
N/A
2032-06-08
Surface Oncology Inc.SURFStelzer Laurie
Director
24,000$024,000
(Direct)
View
2022-06-02
Option Award
2022-06-06
5:59 pm
N/A
2032-06-01
PMV Pharmaceuticals Inc.PMVPStelzer Laurie
Director
19,500$019,500
(Direct)
View
2022-06-01
Option Award
2022-06-03
5:56 pm
N/A
2032-05-31
Mirati Therapeutics Inc.MRTXStelzer Laurie
CFO
148,962$0148,962
(Direct)
View

Ownership
2022-05-16
5:01 pm
N/A
N/A
Mirati Therapeutics Inc.MRTXStelzer Laurie
CFO
0$00
(Direct)
View
2022-03-11
Disposition
2022-03-11
4:12 pm
N/A
N/A
ARENA PHARMACEUTICALS INCARNAStelzer Laurie
EVP & Chief Financial Officer
186,050$037,208
(Direct)
View
2022-03-11
Other
2022-03-11
4:12 pm
N/A
N/A
ARENA PHARMACEUTICALS INCARNAStelzer Laurie
EVP & Chief Financial Officer
37,208$037,208
(Direct)
View
2022-01-03
Option Award
2022-01-05
5:00 pm
N/A
N/A
ARENA PHARMACEUTICALS INCARNAStelzer Laurie
EVP & Chief Financial Officer
21,462$036,366
(Direct)
View
2021-06-08
Option Award
2021-06-10
4:30 pm
N/A
2031-06-08
Surface Oncology Inc.SURFStelzer Laurie
Director
17,700$017,700
(Direct)
View
2021-06-02
Option Award
2021-06-09
5:39 pm
N/A
2031-06-01
PMV Pharmaceuticals Inc.PMVPStelzer Laurie
Director
16,333$016,333
(Direct)
View
2021-03-16
Tax Withholding
2021-04-02
8:10 pm
N/A
N/A
ARENA PHARMACEUTICALS INCARNAStelzer Laurie
EVP & Chief Financial Officer
4,356$76.114,904
(Direct)
View
2021-03-16
Exercise
2021-04-02
8:10 pm
N/A
2022-01-03
ARENA PHARMACEUTICALS INCARNAStelzer Laurie
EVP & Chief Financial Officer
12,600$014,904
(Direct)
View
2021-03-01
Option Award
2021-03-03
9:33 pm
N/A
2028-03-01
ARENA PHARMACEUTICALS INCARNAStelzer Laurie
EVP & Chief Financial Officer
60,710$060,710
(Direct)
View

Ownership
2020-09-24
7:21 pm
N/A
2030-08-11
PMV Pharmaceuticals Inc.PMVPStelzer Laurie
Director
0$032,667
(Direct)
View
2020-06-10
Option Award
2020-06-12
08:00 am
N/A
2030-06-10
Surface Oncology Inc.SURFStelzer Laurie
Director
12,000$012,000
(Direct)
View
2020-03-16
Option Award
2020-03-17
6:47 pm
N/A
2027-03-16
ARENA PHARMACEUTICALS INCARNAStelzer Laurie
EVP & Chief Financial Officer
138,300$0138,300
(Direct)
View
2020-02-22
Tax Withholding
2020-02-24
8:03 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOStelzer Laurie
SVP, Chief Financial Officer
4,508$21.83137,559
(Direct)
View
2020-02-22
Exercise
2020-02-24
8:03 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOStelzer Laurie
SVP, Chief Financial Officer
11,392$0137,559
(Direct)
View
2020-02-14
Exercise
2020-02-18
4:15 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOStelzer Laurie
SVP, Chief Financial Officer
7,809$0134,899
(Direct)
View
2020-02-14
Tax Withholding
2020-02-18
4:15 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOStelzer Laurie
SVP, Chief Financial Officer
2,700$21.1134,899
(Direct)
View
2020-02-12
Tax Withholding
2020-02-13
6:38 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOStelzer Laurie
SVP, Chief Financial Officer
3,894$20114,174
(Direct)
View
2020-02-12
Exercise
2020-02-13
6:38 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOStelzer Laurie
SVP, Chief Financial Officer
11,262$0114,174
(Direct)
View
2020-02-10
Option Award
2020-02-12
5:59 pm
2021-02-10
2030-02-10
HALOZYME THERAPEUTICS INC.HALOStelzer Laurie
SVP, Chief Financial Officer
101,707$0101,707
(Direct)
View
2020-02-03
Exercise
2020-02-04
4:21 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOStelzer Laurie
SVP, Chief Financial Officer
23,119$0106,806
(Direct)
View
2020-02-03
Tax Withholding
2020-02-04
4:21 pm
N/A
N/A
HALOZYME THERAPEUTICS INC.HALOStelzer Laurie
SVP, Chief Financial Officer
8,275$19.21106,806
(Direct)
View
2019-06-15
Tax Withholding
2019-06-17
08:19 am
N/A
N/A
HALOZYME THERAPEUTICS INCHALOStelzer Laurie
SVP, Chief Financial Officer
3,408$15.7391,962
(Direct)
View
2019-06-15
Exercise
2019-06-17
08:19 am
N/A
N/A
HALOZYME THERAPEUTICS INCHALOStelzer Laurie
SVP, Chief Financial Officer
6,875$091,962
(Direct)
View
2019-06-05
Option Award
2019-06-06
4:46 pm
N/A
2029-06-05
Surface Oncology Inc.SURFStelzer Laurie
Director
12,100$012,100
(Direct)
View